{"organizations": [], "uuid": "062176c131af3bdd61b0602c83e269e128fc1448", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 1}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 6, "shares": 6, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.wsj.com", "main_image": "https://images.wsj.net/im-6200/social", "site_section": "https://www.wsj.com/europe", "section_title": "The Wall Street Journal &amp; Breaking News, Business, Financial and Economic News, World News and Video", "url": "https://www.wsj.com/articles/biotech-gets-a-reality-check-1523030490", "country": "US", "domain_rank": 387, "title": "Biotech Gets a Reality Check", "performance_score": 0, "site": "wsj.com", "participants_count": 1, "title_full": "", "spam_score": 0.452, "site_type": "news", "published": "2018-04-07T00:29:00.000+03:00", "replies_count": 0, "uuid": "062176c131af3bdd61b0602c83e269e128fc1448"}, "author": "Charley Grant", "url": "https://www.wsj.com/articles/biotech-gets-a-reality-check-1523030490", "ord_in_thread": 0, "title": "Biotech Gets a Reality Check", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "incyte", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "A major source of biotech sector optimism just took a significant hit.\nThe drug industry has poured billions of dollars into novel drugs that fight cancer, generating exciting results for patients and significant value for biotech investors. It is a problem, then, when potential blockbuster drugs miss the mark.\nCancer specialist Incyte announced... ", "external_links": [], "published": "2018-04-07T00:29:00.000+03:00", "crawled": "2018-04-07T03:53:38.000+03:00", "highlightTitle": ""}